Get started
Author

Marc Lambrechts

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
2015 · M. Schuler, J.C.-H. Yang, et al. · Annals of Oncology · 132
PDF
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer
2024 · David R. Spigel, Afshin Dowlati, et al. · Journal of Clinical Oncology · 48
The genomic landscape of nonsmall cell lung carcinoma in never smokers
2019 · Bram Boeckx, Rajendra B. Shahi, et al. · International Journal of Cancer · 39
PDF
Single-Agent Divarasib in Patients With KRAS G12C –Positive Non–Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study
2025 · Adrian G. Sacher, Wilson H. Miller, et al. · Journal of Clinical Oncology · 35
Endobronchial tuberculosis mimicking lung cancer in elderly patients
1991 · P. Van den Brande, M. Lambrechts, et al. · Respiratory Medicine · 25
Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer: Results from the Belgian compassionate use program
2019 · Sofie Joris, Thierry Pieters, et al. · Journal of Geriatric Oncology · 14
PDF
Cetuximab plus platinum-based chemotherapy in patients with malignant pleural mesothelioma: A single arm phase II trial.
2017 · Annelies De Paepe, Karim Y Vermaelen, et al. · Journal of Clinical Oncology · 9
A phase II single-arm study of induction chemotherapy with cisplatin and gemcitabine followed by concurrent cisplatin and gemcitabine with thoracic radiation for unresectable locally advanced non-small cell lung cancer
2013 · Peter Driesen, Marc Lambrechts, et al. · Therapeutic Advances in Medical Oncology · 9
PDF
Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected!
2022 · Fleur Cordier, Joni Van der Meulen, et al. · Pathology - Research and Practice · 8
PDF
465 Bintrafusp alfa in combination with chemotherapy in patients with stage IV NSCLC: safety and pharmacokinetic results of the INTR@PID LUNG 024 study
2021 · Christian Rolfo, Laurent Greillier, et al. · Journal for ImmunoTherapy of Cancer · 2
PDF
Abstract CT104: Bintrafusp alfa in combination with chemotherapy in patients with stage IV NSCLC: safety results of the INTR@PID LUNG 024 study
2021 · Christian Rolfo, Laurent Greillier, et al. · Cancer Research · 1
Belgian prospective, multicenter, observational study of patients with malignant pleural mesothelioma treated with pemetrexed plus platinum
2014 · Kristiaan Nackaerts, Marc Lambrechts, et al. · European Respiratory Journal
Phase II study of induction chemotherapy with cisplatin (Cis) and gemcitabine (Gem) followed by concomitant Cis-Gem and thoracic radiation (RTX) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)
2009 · P. Driesen, L. Verbeke, et al. · Journal of Clinical Oncology
A randomized phase II feasibility study of adjuvant cisplatin/docetaxel (CisD) or cisplatin/vinorelbine (CisV) in patients (pts) resected stage IB-II non-small cell lung cancer (NSCLC): Interim analysis
2008 · D. Galdermans, P. Driesen, et al. · Journal of Clinical Oncology
Works count: 14
Citation count: 322
H-index: 8
I10-index: 6
Year
Topic
Type